NanoViricides, Inc. Files Quarterly Report - Reports A Strong Cash Position Sufficient For Clinical Trials Of Its First Two Drug Candidates

Published: May 19, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (NYSE MKT: NNVC) (the "Company"), has filed its quarterly report with the Securities and Exchange Commission on Thursday, May 15th, in a timely fashion. The submission can be downloaded from the SEC website at http://www.sec.gov/Archives/edgar/data/1379006/000114420414031119/v378344_10q.htm.

Help employers find you! Check out all the jobs and post your resume.

Back to news